Sleep Disturbances and Their Association With Serum Magnesium Level in Patients With Major Depressive Disorder
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
This cross-sectional study investigates the relationship between serum magnesium levels and the presence of sleep disturbances among patients with major depressive disorder (MDD).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Confirmed diagnosis of major depressive disorder
Disqualifiers
hronic renal failure or metabolic disorders affecting magnesium balance
Trial population
The study sample will include 90 psychiatric patients recruited from the outpatient and inpatient clinics of Assiut University Hospital, representing males and females aged 18-60 years. All participants will have a confirmed diagnosis of major depressive disorder based on clinical criteria and will be evaluated using standardized psychiatric assessment tools. Exclusion criteria were designed to rule out metabolic comorbidities, chronic renal conditions, and medication effects that may confound serum magnesium interpretation. Patients unable to complete questionnaires due to cognitive or language difficulties, as well as those with other psychiatric disorders, will also be excluded.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
90 Participants
are grouped into 1 trial groupGroup A: Adult patients with major depressive disorder
Trial outcomes
Primary outcomes
1
change in the level of serum magnesium level
Serum magnesium concentration (mmol/L) measured by atomic absorption spectrophotometry for the patients.
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: